Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI-Reference-Cited by-同舟云学术

Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

Published:2023-05-03 Issue:10 Volume:33 Page:7003-7014
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Yang Xiefeng,Hu Chengcong,Xing Zhen,Lin Yu,Su Yan,Wang Xingfu,Cao Dairong^ORCID

Funder

The National Natural Science Foundation of China

Fujian Provincial Health Technology Project

The Leading Project of the Department of Science and Technology of Fujian Province

Joint Funds for the Innovation of Science and Technology, Fujian Province

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-023-09695-w.pdf

Reference49 articles.

1. Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251

2. Liu Y, Tang K, Yan W et al (2013) Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas. Neurosci Lett 546:36–41

3. Zeng A, Hu Q, Liu Y et al (2015) IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma. Oncotarget 6:30232–30238

4. Johnson BE, Mazor T, Hong C et al (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343:189–193

5. Kannan K, Inagaki A, Silber J et al (2012) Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget 3:1194–1203

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study;BMC Medical Imaging;2024-08-26

2. Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation;Journal of Neuro-Oncology;2024-06-14

3. Noninvasive assessment of Ki-67 labeling index in glioma patients based on multi-parameters derived from advanced MR imaging;Frontiers in Oncology;2024-05-17

4. The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index;Acta Radiologica;2024-04-22

5. Latest Developments in Magnetic Resonance Imaging for Evaluating the Molecular Microenvironment of Gliomas;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-17